S130
ESTRO 36 2017
_______________________________________________________________________________________________
Purpose or Objective
Currently the first MR-Linac systems (Elekta AB, Sweden)
are being installed at several clinical institutions
worldwide. In order to introduce this new technology
safely into clinic it is imperative that the imaging
component is rigorously tested. In this work we present a
comprehensive set of tests for clinical acceptance and
commissioning of a high field (1.5 Tesla) hybrid MR-Linac
(MRL) system. Guidelines as well as initial results are
presented.
Material and Methods
The complete test protocol consists of a series of general
MRI hardware tests, radiotherapy specific test, and hybrid
tests. General MRI hardware and radiotherapy specific
tests include established tests to allow comparison with
diagnostic and radiotherapy planning 1.5T MRI systems.
The hybrid tests are unique to the design and application
of the MRL and were developed in on a non-clinical MRL
prototype (U1) and performed on the clinical prototype
(U2) after installation in September 2016. Hybrid tests
include: Spurious Noise check, MR-MV alignment, Gantry
influence on B0 homogeneity, and radiation effects.
Finally, sequence specific tests are included to ensure
geometric fidelity of the MRI protocols that will be
performed during clinical use.
Results
Table 1 lists the tests included in the commissioning
protocol, subdivided into six sections. The first four
sections contain quality control (QC) tests, which test the
individual components of the system. The final two
sections include quality assurance (QA) measurements,
which probe overall image quality, and thus test a
combination of several components. The QC
measurements serve as a characterisation of the system,
whereas the QA tests serve as a null measurement before
the system is introduced into clinic.
Fig. 1 shows the results from two independent geometric
fidelity measurements, with a) the vendor provided
geometric fidelity phantom, and b) a third party phantom
[Modus Medical Devices Inc, London, ON, Canada].
Geometric distortions were found to be 0.94mm, 1.82mm,
and 2.35mm for diameter spherical volume (DSV) of
300mm, 350mm, and 400mm, respectively. The maximum
geometric distortion occurred at the edge of the DSV.
Further tests revealed that the influence of the gantry on
magnetic field homogeniety was negligible (<0.1 µT) and
RF flip angle accuracy was within spec and comparable to
our MRI-RT 1.5T Philips Ingenia scanner. Finally, the ACR
resolution, geometry, and low contrast detectability tests
all passed the ACR criteria using diagnostic imaging
protocols (i.e., without additional averaging of the data).
No spurious noise was observed during operation of the
Gantry and Linac, suggesting good decoupling of the two
systems.
Conclusion
A comprehensive acceptance and commissioning protocol
was developed and performed for clinical acceptance of
the first 1.5T MR-Linac within the Atlantic consortium.
Overall system performance is extremely similar to our
diagnostic 1.5T MRI scanner, used for radiotherapy
planning. Hybrid tests showed good decoupling of the two
systems.
OC-0258 Investigation of magnetic field effects on 3D
dosimeters for MR-IGRT applications
H.J. Lee
1,2
, Y. Roed
1,3
, S. Venkataraman
1
, M. Carroll
1,2
, G.
Ibbott
1
1
The University of Texas MD Anderson Cancer Center,
Radiation Physics, Houston, USA
2
University of Texas at Houston, Graduate School of
Biomedical Sciences, Houston, USA
3
University of Houston, Physics, Houston, USA
Purpose or Objective
Conventional QA tools lack the ability to report changes in
volumetric dose distributions and discrepancies out of the
plane of measurement. The strong magnetic field in the
integrated pre-clinical 1.5T MRI – 7MV linear accelerator
system (MR-linac, Elekta AB, Stockholm, Sweden)
influences secondary electrons resulting in changes in dose
deposition in three dimensions. The purpose of this study
was to investigate strong magnetic field effects on 3D
dosimeters for magnetic resonance image-guided
radiation therapy (MR-IGRT) applications.
Material and Methods
There are currently three main types of 3D dosimeters:
radiochromic plastic, radiochromic gel, and polymer gel.
For this study, the following three dosimeters were used:
PRESAGE®, FOX (Fricke-type), and BANG
TM
(MGS Research
Inc). For the purposes of batch consistency, an
electromagnet was used for same-day irradiations with